$1.97
0.51%
Nasdaq, Sep 28, 04:00 pm EDT. Closed.
ISIN
CA29286M1059
Symbol
ENGN

EnGene Target price 2026 - Analyst rating & recommendation

EnGene Classifications & Recommendation

Buy
56%
Hold
39%
Sell
6%

EnGene Price Target

Target Price $4.08
Price $1.97
Potential
Number of Estimates 12
12 Analysts have issued a price target EnGene 2027 . The average EnGene target price is $4.08. This is higher than the current stock price. The highest price target is
$28.35 1,339.09%
register free of charge
, the lowest is .
A rating was issued by 18 analysts: 10 Analysts recommend EnGene to buy, 7 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the EnGene stock has an average upside potential 2027 of . Most analysts recommend the EnGene stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Oct '25 2026
Estimates
Earnings Per Share $ -2.29 -1.78
56.85% 22.27%
P/E negative

13 Analysts have issued a EnGene forecast for earnings per share. The average EnGene EPS is

$-1.78
unlock
. This is
4.30% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-1.64 11.83%
unlock
, the lowest is
$-1.91 2.69%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-2.29 56.85%
2026
$-1.78 22.27%
unlock
2027
$-1.44 19.10%
unlock
2028
$-0.97 32.64%
unlock
2029
$-0.49 49.48%
unlock
2030
$-0.04 91.84%
unlock
2031
$0.34 950.00%
unlock
2032
$0.51 50.00%
unlock
2033
$0.65 27.45%
unlock

P/E ratio

Current -1.06 69.81%
2026
-1.11 4.81%
unlock
2027
-1.37 23.42%
unlock
2028
-2.03 48.18%
unlock
2029
-4.02 98.03%
unlock
2030
-45.99 1,044.03%
unlock
2031
5.85 112.72%
unlock
2032
3.84 34.36%
unlock
2033
3.02 21.35%
unlock

Current EnGene Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Citizens
Locked
➜
Locked
Locked Sep 09 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked Sep 08 2026
Morgan Stanley
Locked
➜
Locked
Locked Jun 18 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked Jun 16 2026
UBS
Locked
➜
Locked
Locked May 14 2026
Wells Fargo
Locked
➜
Locked
Locked May 08 2026
Guggenheim
Locked
➜
Locked
Locked May 08 2026
Analyst Rating Date
Locked
Citizens:
Locked
➜
Locked
Sep 09 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Sep 08 2026
Locked
Morgan Stanley:
Locked
➜
Locked
Jun 18 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Jun 16 2026
Locked
UBS:
Locked
➜
Locked
May 14 2026
Locked
Wells Fargo:
Locked
➜
Locked
May 08 2026
Locked
Guggenheim:
Locked
➜
Locked
May 08 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today